Edited By: C. W. Howden, R. Loomba, G. M. Dusheiko, A. C. Ford, R. B. Gearry, G. L-H. Wong, C. H. Seow, S. Subramanian, J. A. Tye-Din, P. J. Trivedi, D. Q. Huang
Journal list menu
Alimentary Pharmacology & Therapeutics is a global pharmacology journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems, publishing a diverse range of topics in the space often with immediate clinical impact to our readership.
We are interested in therapies and diagnostics, including all aspects of translation from bench to bedside and clinical trials.
Thirteen good reasons why authors prefer AP&T
✮2023 Impact Factor is 6.6, ranking AP&T 18/143 for journals in Gastroenterology & Hepatology.
✮Quick decisions: Submission to first decision in 11 days on average in 2023.
✮FREE submission.
✮FREE colour figures.
✮No overall word count limit for original articles.
✮Fast publication: only 7 weeks from acceptance to publication in an online issue, with its final and full citation.
✮Possible Transfer Option to scope-matched journals for papers rejected by AP&T.
✮Follow @APandT for daily links to the latest articles.
✮Google Scholar: AP&T now ranks at number 12 in Google Scholar’s list of top publications in Gastroenterology & Hepatology.
✮AP&T's 2023 SCImago SJR is 2.794, ranking it 8/164 in Gastroenterology and 10/80 in Hepatology.
✮FREE PDF off-prints for all authors.
✮Open Access publishing: after full peer-review, authors can choose to publish open access.
✮'Early View': The final corrected proofs of each article are published 16-24 days after acceptance, and listed by PubMed only days later.
Most read articles
AP&T Podcasts
Articles
Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Addressing key methodological and regional challenges
-  1154-1155
-  23 September 2024
LINKED CONTENT
This article is linked to Danpanichkul et al papers. To view these articles, visit https://doi.org/10.1111/apt.18101 and https://doi.org/10.1111/apt.18250
Editorial: Does ESWL-ERCP for pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis?
-  1130-1131
-  17 September 2024
LINKED CONTENT
This article is linked to Yiu et al papers. To view these articles, visit https://doi.org/10.1111/apt.18224 and https://doi.org/10.1111/apt.18284
Editorial: Does ESWL-ERCP for pancreatic duct stone removal change the natural course of symptomatic chronic calcific pancreatitis? Authors' reply
-  1132-1133
-  17 September 2024
LINKED CONTENT
This article is linked to Yiu et al papers. To view these articles, visit https://doi.org/10.1111/apt.18224 and https://doi.org/10.1111/apt.18253
Editorial: Plants against animals
-  955-956
-  12 September 2024
LINKED CONTENT
This article is linked to Choi et al paper. To view this article, visit https://doi.org/10.1111/apt.18116
Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
-  1122-1123
-  9 September 2024
LINKED CONTENT
This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18266
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Review article: the role of butyrate on colonic function
-  104-119
-  26 October 2007
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
-  274-285
-  30 May 2011
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress
-  395-402
-  2 October 2003
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection
-  868-876
-  12 February 2018
Abstract
Linked Content
This article is linked to Zamani et al and Tsipotis and Leontiadis papers. To view these articles visit https://doi.org/10.1111/apt.14609 and https://doi.org/10.1111/apt.14618.
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
-  1044-1060
-  8 October 2018